Skip to Content

'
Katherine M.W. Pisters, M.D., F.A.C.P.

Present Title & Affiliation

Primary Appointment

Professor, Department of Thoracic/Head and Neck Medical Oncology, Division of Cancer Medicine, The University of Texas MD Anderson Cancer Center, Houston, TX
Associate Administrative Director, Division of Cancer Medicine, The University of Texas MD Anderson Cancer Center, Houston, TX
Committee Member, ASCO NSCLC, -

Office Address

The University of Texas MD Anderson Cancer Center
Department of Thoracic Head and Neck Medical Oncology
1400 Holcombe Blvd., Unit 432
Unit Number: Unit 432
Houston, TX 77030
Room Number: FC9.2042

Education & Training

Postgraduate Training

1989-1990 Chief Medical Resident, Memorial Sloan-Kettering Cancer Center, New York, NY
1988-1991 Clinical Fellowship, Memorial Sloan-Kettering Cancer Center, New York, NY
1986-1988 Clinical Residency, Internal Medicine, The Cornell Hospitals, North Shore University Hospital & Memorial Hospital, New York, NY
1985-1986 Clinical Internship, The Cornell Hospitals, North Shore University Hospital & Memorial Hospital, New York, NY

Board Certifications

2002 American Board of Internal Medicine/Medical Oncolo
1988 American Board of Internal Medicine

Experience/Service

Academic Appointments

Internist, Department of Thoracic/Head and Neck Medical Oncology, Division of Cancer Medicine, The University of Texas M.D. Anderson Cancer Center, Houston, TX, 2005-present

Other Appointments/Responsibilities

Editorial Board, Clinical Lung Cancer, ---, 2006-present

Selected Publications

Peer-Reviewed Original Research Articles

1. Ettinger DS, Akerley W, Borghaei H, Chang A, Cheney RT, Chirieac LR, D'Amico TA, Demmy TL, Ganti AK, Govindan R, Grannis FW, Horn L, Jahan TM, Jahanzeb M, Kessinger A, Komaki R, Kong FM, Kris MG, Krug LM, Lennes IT, Loo BW, Martins R, O'Malley J, Osarogiagbon RU, Otterson GA, Patel JD, Schenck MP, Pisters KM, Reckamp K, Riely GJ, Rohren E, Swanson SJ, Wood DE, Yang SC. Malignant pleural mesothelioma. Clinical practice guidelines in oncology. J Natl Compr Canc Netw 10(1):26-41, 1/1/2012. PMID: 22223867.
2. Ettinger DS, Akerley W, Bepler G, Blum MG, Chang A, Cheney RT, Chirieac LR, D'Amico TA, Demmy TL, Govindan R, Grannis FW, Jahan T, Johnson DH, Kessinger A, Komaki R, Kong FM, Kris MG, Krug LM, Le QT, Lennes IT, Martins R, O'Malley J, Osarogiagbon RU, Otterson GA, Patel JD, Pisters KM, Reckamp K, Riely GJ, Rohren E, Swanson SJ, Wood DE, Yang SC, National Comprehensive Cancer Network. Thymic malignancies. J Natl Compr Canc Netw 8(11):1302-15, 11/2010. PMID: 21081786.
3. Pisters KM, Vallières E, Crowley JJ, Franklin WA, Bunn PA, Ginsberg RJ, Putnam JB, Chansky K, Gandara D. Surgery with or without preoperative paclitaxel and carboplatin in early-stage non-small-cell lung cancer: Southwest Oncology Group Trial S9900, an intergroup, randomized, phase III trial. J Clin Oncol 28(11):1843-9, 4/2010. e-Pub 3/2010. PMCID: PMC2860367.
4. Kassis ES, Vaporciyan AA, Swisher SG, Correa AM, Bekele BN, Erasmus JJ, Hofstetter WL, Komaki R, Mehran RJ, Moran CA, Pisters KM, Rice DC, Walsh GL, Roth JA. Application of the revised lung cancer staging system (IASLC Staging Project) to a cancer center population. J Thorac Cardiovasc Surg 138(2):412-418.e1-2, 8/2009. e-Pub 5/28/2009. PMCID: PMC2731793.
5. Bolton WD, Rice DC, Correa AM, Hofstetter W, Komaki R, Mehran R, Pisters K, Roth JA, Vaporciyan AA, Walsh GL, Swisher SG. Influence of age on choice of therapy and surgical outcomes in patients with nonsmall cell lung cancer. Am Surg 75(7):598-603; discussion 603-4, 7/2009. PMID: 19655604.
6. Krug LM, Pass HI, Rusch VW, Kindler HL, Sugarbaker DJ, Rosenzweig KE, Flores R, Friedberg JS, Pisters K, Monberg M, Obasaju CK, Vogelzang NJ. Multicenter Phase II Trial of Neoadjuvant Pemetrexed Plus Cisplatin Followed by Extrapleural Pneumonectomy and Radiation for Malignant Pleural Mesothelioma. J Clin Oncol 27(18):3007-13, 6/2009. e-Pub 4/2009. PMID: 19364962.
7. Bolton WD, Rice DC, Goodyear A, Correa AM, Erasmus J, Hofstetter W, Komaki R, Mehran R, Pisters K, Roth JA, Swisher SG, Vaporciyan AA, Walsh GL, Weaver J, Rhines L. Superior sulcus tumors with vertebral body involvement: a multimodality approach. J Thorac Cardiovasc Surg 137(6):1379-87, 6/2009. PMID: 19464452.
8. Carmack Taylor CL, Badr H, Lee JH, Fossella F, Pisters K, Gritz ER, Schover L. Lung cancer patients and their spouses: psychological and relationship functioning within 1 month of treatment initiation. Ann Behav Med 36(2). e-Pub 9/2008. PMID: 18797978.
9. Zinner RG, Komaki R, Cox JD, Glisson BS, Pisters KM, Herbst RS, Kies M, Liao Z, Hong WK, Fossella FV. Dose escalation of gemcitabine is possible with concurrent chest three-dimensional rather than two-dimensional radiotherapy: a phase I trial in patients with stage III non-small-cell lung cancer. Int J Radiat Oncol Biol Phys 73(1). e-Pub 6/2008. PMID: 18556142.
10. Pisters KM, Evans WK, Azzoli CG, Kris MG, Smith CA, Desch CE, Somerfield MR, Brouwers MC, Darling G, Ellis PM, Gaspar LE, Pass HI, Spigel DR, Strawn JR, Ung YC, Shepherd FA, Shepherd FA, Shepherd FA. Cancer Care Ontario and American Society of Clinical Oncology adjuvant chemotherapy and adjuvant radiation therapy for stages I-IIIA resectable non small-cell lung cancer guideline. J Clin Oncol 25(34). e-Pub 10/2007. PMID: 17954710.
11. Scott WJ, Howington J, Feigenberg S, Movsas B, Pisters K, Pisters K. Treatment of non-small cell lung cancer stage I and stage II: ACCP evidence-based clinical practice guidelines (2nd edition). Chest 132(3 Suppl):234S-242S, 9/2007. PMID: 17873171.
12. Pisters KM, Darling G. The IASLC Lung Cancer Staging Project: "the nodal zone". J Thorac Oncol 2(7):583-4, 7/2007. PMID: 17607110.
13. Strasser F, Palmer JL, Schover LR, Yusuf SW, Pisters K, Vassilopoulou-Sellin R, DeGracia B, Willey JS, Bruera E. The impact of hypogonadism and autonomic dysfunction on fatigue, emotional function, and sexual desire in male patients with advanced cancer: a pilot study. Cancer 107(12):2949-57, 12/2006. PMID: 17103445.
14. Thomas SK, Fossella FV, Liu D, Schaerer R, Tsao AS, Kies MS, Pisters KM, Blumenschein GR, Jr, Glisson BS, Lee JJ, Herbst RS, Zinner RG. Asian ethnicity as a predictor of response in patients with non-small cell lung cancer treated with gefitinib on an expanded access program. Clin Lung Cancer 7(5)(5):326-31, 3/2006. PMID: 16640804.
15. Kim ES, Kies MS, Fossella FV, Glisson BS, Zaknoen S, Statkevich P, Munden RF, Summey C, Pisters KM, Papadimitrakopoulou V, Tighiouart M, Rogatko A, Khuri FR. Phase II study of the farnesyltransferase inhibitor lonafarnib with paclitaxel in patients with taxane-refractory/resistant nonsmall cell lung carcinoma. Cancer 104(3):561-9, 8/1/2005. PMID: 16028213.
16. Pisters KM, Le Chevalier T. Adjuvant chemotherapy in completely resected non-small-cell lung cancer. J Clin Oncol 23(14):3270-8, 5/2005. PMID: 15886314.
17. Pisters KM. Adjuvant chemotherapy for non-small-cell lung cancer. Clin Adv Hematol Oncol 1(9):533-7, 9/2003. PMID: 16258445.
18. Pisters KM, Newman RA, Coldman B, Shin DM, Khuri FR, Hong WK, Glisson BS, Lee JS. Phase I trial of oral green tea extract in adult patients with solid tumors. J Clin Oncol 19(6):1830-8, 3/2001. PMID: 11251015.
19. Pisters KM, Ginsberg RJ, Giroux DJ, Putnam JB, Jr, Kris MG, Johnson DH, Roberts JR, Mault J, Crowley JJ, Bunn PA, Jr. Induction chemotherapy before surgery for early-stage lung cancer: A novel approach. Bimodality Lung Oncology Team. J Thorac Cardiovasc Surg 119(3):429-39, 3/2000. PMID: 10694600.
20. Pisters KM, Kris MG, Gralla RJ, Zaman MB, Heelan RT, Martini N. Pathologic complete response in advanced non-small-cell lung cancer following preoperative chemotherapy: implications for the design of future non-small-cell lung cancer combined modality trials. J Clin Oncol 11(9):1757-62, 9/1993. PMID: 8394881.

Invited Articles

1. Pisters KMW. Adjuvant chemotherapy for resected non-small cell lung cancer. . Oncology, 2005.
2. Johnson, FM, Kurie JM, Peeples BO, Pisters KM, Fossella FV, Papadimitrakopoulou VA, Blumenschein GR, Komaki R, Glisson BS. Dose-Dense Therapy With a Novel Irinotecan Regimen for Small-Cell Lung Cancer. . Oncology (Williston Park) 17(7):17-21, 2003. PMID: 12886869.
3. Pisters KMW. Stage I/II non-small cell lung cancer: Is there a role for combined-modality therapy? . ASCO 2002 Educational Book:465-470, 2002.
4. Pisters KMW. Adjuvant and neoadjuvant therapy for early stage non-small cell lung cancer. Semin Oncol 28(14):23-28, 2001.
5. Pisters KMW. Adjuvant and neoadjuvant therapy for early-stage non-small cell lung cancer. Sem Oncol 28(4):23-28, 2001.
6. Pisters KMW. Adjuvant therapy after definitive surgery. Lung Cancer 34(1), 2001.
7. Pisters KMW. Editorial on adjuvant chemotherapy. . Hematology & Oncology, 2001.
8. Pisters KMW. Neoadjuvant therapy for early stage lung cancer. . The Society of Thoracic Surgeons, 2001.
9. Pisters KMW. Adjuvant systemic and local therapy in the postoperative setting: Is there benefit? . ASCO 2000 Clinical Practice Forum Book:3-7, 2000.
10. Pisters KMW. Induction chemotherapy for early-stage lung cancer. . Lung Cancer 29(2):126, 2000.
11. Pisters KMW. The role of chemotherapy in early stage (stage I and II) resectable non-small cell lung cancer. . Semin Radiat Oncol 10(4):274-279, 2000.
12. Pisters KMW . Combined modality therapy for Lung Cancer. . Medscape Oncology Conference Summaries, 5/1999.
13. Pisters KMW . Early stage NSCLC: Updates on Management and therapy. Medscape Oncology Conference Summaries, 5/1999.
14. Swisher, SG, Roth JA, Lawrence DD, Kemp BL, El-Naggar AK, Cristiano JR, Fang B, Glisson BS, Hong WK, Khuri FR, Kurie JM, Lee JJ, Lee JS, Merritt JA, Mukhopadhyay T, Nesbitt JC, Perez-Soler R, Pisters KMW, Putnam JB, Schrump DS, Shin DM, Walsh GL. Gene therapy in oncology: Clinical challenges, needs and prospects, as reflected in p53 gene replacement in NSCLC. . Sem Oncol, 1999.
15. Pisters KMW. Phase III Intergroup trial: Induction paclitaxel/carboplatin chemotherapy followed by surgery vs. surgery only in early-stage non-small cell lung cancer. . Thoracic Oncology Newsletter, 1999.
16. Pisters KMW . Diagnosis and prognosis of lung cancer and mesothelioma. Clinical Care Options for Oncology Conference Summaries, 5/1998.
17. Pisters KMW. NSCLC trials involving thoracic surgery. . Clinical Care Options for Oncology Conference Summaries,, 5/1998.
18. Pisters KMW. BLOT Trial: Phase II trial of induction paclitaxel/carboplatin in clinical stage IB (T2N0), II (T1-2N1, T3N0) and selected IIIA (T3N1) non-small cell lung cancer. Current Clinical Trials in Thoracic Oncology, 1998.
19. Roth, JA, Swisher SG, Merritt JA, Lawrence DD, Kemp BL, Carrasco CH, El-Naggar EK, Fossella FV, Glisson BS, Hong WK, Khuri FR, Kurie JM, Nesbitt JC, Pisters KMW, Putnam JB, Schrump DS, Shin DM, Walsh GL. Gene therapy for non-small cell lung cancer: A preliminary report of a phase I trial of adenoviral p53 gene replacement. . Semin Oncol 25(8):33-337, 1998.
20. Kris, MG, Pizzo BA, Pisters KMW. Delayed emesis following cisplatin: Progress and prospects. Pharmacy and Therapeutics 22(7S):12S-17S, 1997.
21. Pisters, KMW, Ginsberg RJ. Induction chemotherapy for early stage lung cancer. Adv Oncol 13:25-29, 1997.
22. Pisters, KMW, Kris MG, Bunn PA, Jr, Johnson DH, Ruckdeschel JC, Crowley JJ, Ginsberg RJ,. Induction paclitaxel/carboplatin in early stage non-small cell lung cancer. Sem Oncol 24(12):S12-41/S12-44, 1997.
23. Pisters KMW. Multidisciplinary approach to potentially curable non-small cell carcinoma of the lung. Oncology 11:44,49, 1997.
24. Lee, JS, Pisters KMW, Komaki R, Glisson BS, Khuri FR, Schea R, Fossella FV. Paclitaxel/carboplatin chemotherapy as primary treatment of brain metastases in non-small cell lung cancer: A preliminary report. Sem Oncol 24(12):S12-52/S12-55, 1997.
25. Kris, MG, Pisters KMW, Ginsberg RJ, Rigas JR, Miller VA, Grant SC, Gralla RJ, Heelan RT, Martini N. Effectiveness and toxicity of preoperative therapy in Stage IIIA non-small cell lung cancer including the Memorial Sloan-Kettering experience with induction MVP in patients with bulky mediastinal lymph node metastases (Clinical N2). Lung Cancer 12(1):S47-S57, 1995.
26. Kris, MG, Pisters KMW, Hinkley L. Delayed emesis following anticancer chemotherapy. Support Care Cancer 2:297-300, 1994.
27. Pisters, KMW, Kris MG. Granisetron to prevent vomiting after cancer chemotherapy. Medical Letter, 1994.
28. Kris, MG, Baltzer L, Hinkley L, Pisters KMW. Strategies to control vomiting caused by anticancer drugs. . Adv Biosciences 91:391-397, 1994.
29. Pisters, KMW, Kris MG. Drugs for nausea caused by cancer chemotherapy. Medical Letter 35(912):124-126, 1993.
30. Kris, MG, Martini N, Gralla RJ, Pisters KMW, Heelan RT. Primary chemotherapy in stage IIIA non-small cell lung cancer patients with clinically apparent mediastinal lymph node metastases: Focus on five-year survivors. Lung Cancer 9:369-376, 1993.

Editorials

1. Pisters KM. Postoperative adjuvant chemotherapy for stage IB NSCLC. Abstracts in Hematology & Oncology 10(2):3-5, 2007.
2. Pisters KMW, Darling G. The IASLC Lung Cancer Staging Project: “The Nodal Zone”. J Thorac Oncol 2(7):583-584, 2007.
3. Pisters KM. Adjuvant chemotherapy for non-small cell lung cancer.The Smoke Clears. . N Engl J Med 352;25(25):2640-2642, 2005. PMID: 15972872.
4. Pisters KM. Adjuvant chemotherapy for resected non-small cell lung cancer. Oncology, 2005.
5. Pisters KM. Editorial on adjuvant chemotherapy. Abstracts in Hematology & Oncology, 2001.
6. Pisters KM. Multidisciplinary approach to potentially curable non-small cell carcinoma of the lung. Oncology 11:44,49, 1997.
Other Articles
1. Pisters KMW . Induction chemotherapy in early-stage non-small cell lung cancer. . Curr Oncol Rep 5(4):307-308, 2003. PMID: 12781072.

Abstracts

1. L. M. Krug, H. Pass, V. W. Rusch, H. L. Kindler, D. Sugarbaker, K. Rosenzweig, J. S. Friedberg, K. Pisters, C. K. Obasaju, N. J. Vogelzang. A multicenter U.S. trial of neoadjuvant pemetrexed plus cisplatin (PC) followed by extrapleural pneumonectomy (EPP) and hemithoracic radiation (RT) for stage I-III malignant pleural mesothelioma (MPM). Journal of Clinical Oncology 2007 ASCO Annual Meeting Proceedings Part I; 25:18S (#A7561), 2007.
2. J. Uyeki, F. M. Johnson, L. Feng, B. O. Peeples, G. J. Blumenschein, F. V. Fossella, D. D. Karp, K. M. Pisters, D. J. Stewart, B. S. Glisson. Phase II trial of irinotecan plus cisplatin (IP) and etoposide plus cisplatin (EP) given weekly on alternating weeks with granulocyte colony-stimulating factor support in the treatment of extensive-stage small cell lung cancer. Journal of Clinical Oncology ASCO Annual Meeting Proceedings Part I; 25:18S (#A18119), 2007.
3. K. Pisters, E. Vallieres, P. A. Bunn, J. Crowley, K. Chansky, R. Ginsberg, D. R. Gandara,. Southwest Oncology Group. S9900: Surgery alone or surgery plus induction (ind) paclitaxel/carboplatin (PC) chemotherapy in early stage non-small cell lung cancer (NSCLC): Follow-up on a phase III trial. Journal of Clinical Oncology ASCO Annual Meeting Proceedings Part I. Vol 25, No. 18S (#7520), 2007.
4. Carmack Taylor CL, Badr H, Basen-Engquist K, Li JH, Gorman A, Pisters K, Fossella F, Schover L. Spousal relationship satisfaction buffers the association between patient and spouse psychological distress when facing lung cancer, 2006.
5. Koshy S, Fossella F, Liu D, Schaerer R, Tsao A, Kies M, Pisters K, Lee J, Herbst R, Zinner R. Asian ethnicity as a predictor of response to gefitinib in non-small cell lung cancer. Lung Cancer 49(suppl 2):S253 (#Abstract P-518), 2005.
6. Pisters K, Vallieres E, Bunn P, Crowley J, Ginsberg R, Ellis P, Meyers B, Marks R, Treat J, Gandara D. S9900: A phase III trial of surgery alone or surgery plus preoperative paclitaxel/carboplatin chemotehrapy in early stage non-small cell lung cancer: Preliminary results. Proc Am Soc Clin Oncol 24 (#abstract #7012), 2005.
7. Vallieres E, Pisters K, Crowley J, Chansky K, Bunn P, Gandara D. S9900: Preliminary surgical results of a phase III trial of surgery alone or surgery plus preoperative paclitaxel/carboplatin chemotherapy in early stage non-small cell lung cancer. Lung Cancer 49 (suppl 2):s43 (#Abstract O-124), 2005.
8. Carmack, Taylor CL, Badr H, Basen-Engquist K, Hall T, Ellickalputhenpura B, Pisters K, Fossella F. Spousal relationships and psychological distress in lung cancer patients and their spouses. Annals of Behavioral Medicine 29:S101, 2005.
9. Koshy, S, Herbst RS, Obasaju CK, Fossella F, Papadimitrakopoulou V, Pisters KMW, Blumenschein G, Peeples BO, Hong WK, Zinner RG. A phase II trial of pemetrexed plus carboplatin in patients with advanced non-small cell lung cancer. Proc Am Soc Clin Oncol 23:631a, 2004.
10. Bruera, E, Willey J, Palmer JL, Morice R, Pisters K. A randomized controlled trial of supplemental oxygen versus air in cancer patients with dyspnea. 8th Congress of the European Association for Palliative Care, 4/2003.
11. Zinner, RG, Obasaju CK, Fossella FV, Pisters KMW, Papadimitrakopoulou VA, Varghese B, Peeples BO, Haftield AK, Hong WK, Herbst RS. A phase II trial of alimta plus carboplatin in patients with advanced non-small cell lung cancer. Lung Cancer 41(suppl 2):223 (#Abstract P-522), 2003.
12. Zinner, R, Obasaju CK, Fossella FV, Papadimitrakopoulou VA, Pisters KMW, O’Day MR, Peeples BO, Hatfield AK, Hong WK, Herbst RS. Alimta plus carboplatin in patients with advanced non-small cell lung cancer: A phase II trial. Proc Am Soc Clin Oncol 22:642a, 2003.
13. Pisters, K, Ginsberg R, Giroux D, Kris M, Putnam JB, Roberts JR, Johnson D, Crowley J, Bunn PA. Bimodality Lung Oncology Team trial of induction paclitaxel/carboplatin in early stage non-small cell lung cancer: Long term followup of a phase II trial. Proc Am Soc Clin Oncol 22:633a, 2003.
14. Komaki R, Glisson B, Allen P, Fossella F, Liao Z, Stevens C, Blumenschein G, Hong WK, Herbst R, Pisters K. Hyperfractionated and accelerated thoracic radiation therapy increased survival compared to daily TRT for limited small cell lung cancer patients treated with concurrent chemotherapy. Lung Cancer 41(suppl 2):24 (#Abstract O-71), 2003.
15. Blumenschein, GR, Fossella FV, Pisters KMW, Khuri FR, Lu C, Kies MS, Glisson BS, Zinner R, Crane E, Schaerer R, Dordal M, Goodin T, Hong WK, Herbst RS. A phase I study of TNP-470 continuous infusion alone or in combination with paclitaxel and carboplatin in adult patients with NSCLC and other solid tumors. Proc Am Soc Clin Oncol 21(314a), 2002.
16. Kim, ES, Mauer AM, Fossella FV, Jamison TA, Kies MS, Pisters KM, Glisson BS, Blumenschein GR, Zinner RG, Tran HT, Windt P, Lie D, Khuri F, Dicke K, Needle M, Vokes EE, Hong WK, Herbst RS. A phase II study of erbitux (IMC-C225), an epidermal growth factor receptor (EGFR) blocking antibody, in combination with docetaxel in chemotherapy refractory/resistant patients with advanced non-small cell lung cancer. Proc Am Soc Clin Oncol 21:293a, 2002.
17. Tran, HT, Herbst RS, Glisson BS, Pisters KM, Khuri FR, Oh YW, Ordonea NG, Lee P, El-Naggar AK, Hong WK, Zinner RG. Herceptin in combination with cisplatin and gemcitabine in patients with HER2 overexpressing, untreated, advanced, non-small cell lung cancer: final report of a phase II trial. . Proc Am Soc Clin Oncol 21(307a), 2002.
18. Johnson, FM, Kurie JM, Pisters KM, Fossella FV, Peeples BO, Papadimitrakopoulou VA, Blumenschein GR, Kies MS, Komaki R, Glisson BS. Phase I trial of weekly etoposide, cisplatin, and irinotecan with G-CSF in patients with small-cell lung cancer. Proc Am Soc Clin Oncol 21(312a), 2002.

Book Chapters

1. Ettinger DS, Akerley W, Borghaei H, Chang AC, Cheney RT, Chirieac LR, D'Amico TA, Demmy TL, Ganti AK, Govindan R, Grannis FW, Horn L, Jahan TM, Jahanzeb M, Kessinger A, Komaki R, Kong FM, Kris MG, Krug LM, Lennes IT, Loo BW, Martins R, O'Malley J, Osarogiagbon RU, Otterson GA, Patel JD, Pinder-Schenck MC, Pisters KM, Reckamp K, Riely GJ, Rohren E, Swanson SJ, Wood DE, Yang SC, Hughes M, Gregory KM. Non-small cell lung cancer. . In: J Natl Compr Canc Netw. 10, 10. in press, 1236-71, 10/1/2012. ISBN: 23054877.
2. Ettinger DS, Akerley W, Bepler G, Blum MG, Chang A, Cheney RT, Chirieac LR, D'Amico TA, Demmy TL, Ganti AK, Govindan R, Grannis FW, Jahan T, Jahanzeb M, Johnson DH, Kessinger A, Komaki R, Kong FM, Kris MG, Krug LM, Le QT, Lennes IT, Martins R, O'Malley J, Osarogiagbon RU, Otterson GA, Patel JD, Pisters KM, Reckamp K, Riely GJ, Rohren E, Simon GR, Swanson SJ, Wood DE, Yang SC, NCCN Non-Small Cell Lung Cancer Panel Members. Non-Small Cell Lung Cancer. In: J Natl Compr Canc Netw. 8, 7. PRR Inc, 740-801, 7/2010. ISBN: 20679538.
3. Pisters KMW. Multimodality management of early stage lung cancer. . In: Advanced Therapy in Thoracic Surgery. B.C. Decker Inc, 61-67, 2005.
4. Pisters, KMW, Mirkovic N, Pass HI, Albain KS. Preoperative Chemotherapy/Radiation Therapy for Early Stage and Locally Advanced Non-Small Cell Lung Carcinoma Disease. In: Lung Cancer: Principles and Practice. Lippincott, 626-649, 2005.
5. Pisters KMW . Combined modality therapy of early stage non-small cell lung cancer. In: Respir Care Clin N Am. 9, 2. Saunders, 191-205, 2003. ISBN: 12911289.
6. Vaporciyan, AA, Kelly JF, Pisters KMW. Prevention and management of sequelae of multimodality therapy. In: M. D. Anderson Cancer Series, Lung Cancer. Springer, New York, Inc, 241-255, 2002.
7. Walsh, GL, Pisters KMW, Stevens C. Treatment of stage I lung cancer: The past, present and future. In: Chest Surgery Clinics of North America. 11, 17-38, 2001.
8. Gralla, RJ, Pisters KMW, Kris MG. Chemotherapy-induced nausea and vomiting. In: Cancer Management: A Multidisciplinary Approach. PRR Inc, 735-746, 2000.
9. Pisters KMW. Postoperative adjuvant chemotherapy in non-small cell lung cancer. In: Lung Cancer: Principles and Practice. Lippincott Williams & Wilkins, 769-777, 2000.
10. Pisters, KMW, Kris MG. Prevention of chemotherapy induced nausea and vomiting. In: Cancer Management: A Multidisciplinary Approach. PRR Inc, 689-700, 2000.
11. Pisters, KMW, Kris MG. Chemotherapy-induced nausea and vomiting. . In: Cancer Management: A Multidisciplinary Approach. PRR Inc, 723-734, 1998.
12. Pisters, KMW, Kris MG. Treatment-related nausea and vomiting. . In: Principles and Practice of Supportive Oncology. Lippincott-Raven, 165-178, 1998.
13. Pisters, KMW, Kris MG. Nausea and vomiting. In: Conn’s Current Therapy. W. B. Saunders Company, 48, 1995.
14. Pisters, KMW, Kris MG, Hilaris B, McCormack PM, Bains MS, Gralla RJ, Martini N. Randomized trial of postoperative vindesine and cisplatin in patients with stage III (T1-3N2M0) non-small cell lung cancer. . In: Adjuvant Therapy of Cancer VII. J. B. Lippincott Company, 118-124, 1993.
15. Kris, MG, Tyson LB, Baltzer L, Pisters KMW. Clinical trials in acute cancer chemotherapy-induced vomiting. . In: Mechanisms and Control of Emesis. 223. John Libbey Eurotext Limited, 129-139, 1992.
16. Pisters, KMW, Rivera MP, Kris MG. Acute toxicities of cancer therapy. . In: Critical Care of the Cancer Patient. Mosby Year-Book, Inc., 1-12, 1991.
17. Pisters, KMW, Kris MG. Management of nausea and vomiting caused by anticancer drugs: State of the art. In: Quality of Life in Current Oncology Practice and Research. Dominus Publishing Co, 107-112, 1991.
18. Pisters, KMW, Kris MG, Gralla RJ, Martini N. Preoperative chemotherapy in stage IIIA non-small cell lung cancer: An analysis of a trial in patients with clinically apparent mediastinal node involvement. In: Adjuvant Therapy of Cancer VI. W. B. Saunders Company, 133-137, 1990.

Letters to the Editor

1. Rice D, Swisher S, Pisters K, Fossella F, Herbst R, Hofstetter W, Kies M, Komaki R, Lippman S, Mehran R, Roth J, Stewart D, Vaporciyan A, Walsh G, Cox J. Comment on "Treatment of non-small cell lung cancer stage IIIA: ACCP evidence-based clinical practice guidelines (2nd edition)". Chest 134(6):1349; author reply 1350, 12/2008. PMID: 19059972.

Last updated: 8/27/2013